Company Valuation: Mesa Laboratories, Inc.

Data adjusted to current consolidation scope
Fiscal Period: March 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 1,337 934.1 591.9 644.8 488.5 690 -
Change - -30.14% -36.64% 8.93% -24.23% 41.25% -
Enterprise Value (EV) 1,506 1,084 591.9 644.8 488.5 690 690
Change - -27.99% -45.42% 8.93% -24.23% 41.25% 0%
P/E 728x 1,028x -2.32x -330x 73.1x 58x 44.4x
PBR 3.41x 2.38x 4.07x 4.05x 2.62x 3.53x 3.21x
PEG - -20x 0x 3.3x -0x 0.8x 1.5x
Capitalization / Revenue 7.25x 4.26x 2.74x 2.68x 1.96x 2.71x 2.55x
EV / Revenue 0x 0x 0x 0x 0x 2.71x 2.55x
EV / EBITDA 0x 0x 0x 0x 0x 11.2x 9.84x
EV / EBIT 0x 0x 0x 0x 0x 11.4x 10.5x
EV / FCF 0x 0x 0x 0x 0x 15.5x 14.8x
FCF Yield 2.6% 2.51% 7.02% 6.6% 8.1% 6.43% 6.77%
Dividend per Share 2 0.64 0.64 0.64 0.64 0.64 0.64 0.64
Rate of return 0.25% 0.37% 0.58% 0.54% 0.72% 0.52% 0.52%
EPS 2 0.35 0.17 -47.2 -0.36 1.21 2.125 2.775
Distribution rate 183% 376% -1.36% -178% 52.9% 30.1% 23.1%
Net sales 1 184.3 219.1 216.2 241 249.1 254.4 270.8
EBITDA 1 41.16 49.68 50.5 56.74 63.49 61.4 70.1
EBIT 1 37.9 45.82 50.5 51.36 58.23 60.5 65.9
Net income 1 1.871 0.93 -254.2 -1.974 6.712 12.7 17.35
Net Debt 169 150.4 - - - - -
Reference price 2 254.88 174.73 109.73 118.66 88.42 123.30 123.30
Nbr of stocks (in thousands) 5,246 5,346 5,394 5,434 5,525 5,596 -
Announcement Date 31/05/22 25/05/23 05/06/24 28/05/25 27/05/26 - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
58.03x - - 0.52% 69Cr
30.7x4.06x15.71x2.44% 18TCr
19.83x3.46x12.37x3.06% 11TCr
23.23x4.55x15.85x1.21% 11TCr
26.93x2.64x10.6x2.68% 7.84TCr
18.65x0.21x13.46x0.7% 6.49TCr
31.09x7.72x19.92x1.28% 5.4TCr
36.76x3.52x12.05x2.06% 5.2TCr
37.64x9.35x26.14x-.--% 4.38TCr
34.55x6.06x19.02x-.--% 3.24TCr
Average 31.74x 4.62x 16.13x 1.39% 7.34TCr
Weighted average by Cap. 27.46x 4.19x 15.29x 1.85%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Mesa Laboratories, Inc.

Historical PBR trend

Valuation ratios - PBR - Mesa Laboratories, Inc.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Mesa Laboratories, Inc.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Mesa Laboratories, Inc.


Year-on-year evolution of the Yield

Valuation ratios - Yield - Mesa Laboratories, Inc.
  1. Stock Market
  2. Stocks
  3. MLAB Stock
  4. Valuation Mesa Laboratories, Inc.